资讯
内科
心血管
肿瘤
内分泌
普通内科
消化
呼吸
神经科
传染科
精神心理
肾内科
风湿免疫
血液科
老年医学
外科
头颈外科
胃肠外科
血管外科
肝胆胰外
骨科
普通外科
胸心外科
神经外科
泌尿外科
烧伤科
整形美容
麻醉疼痛
专科科室
罕见病
康复医学
药械
儿科
耳鼻咽喉
口腔科
眼科
政策人文
营养全科
预防公卫
妇产科
中医科
急重症
皮肤性病
影像放射
转化医学
检验病理
护理
热点
临床研究
研究设计
人工智能
智慧医疗
论文基金
医学科普
药物经济
医生集团
职业安全
患者招募
医学科研
公司产业
医学英语
MedSci动态
指南
按科室浏览
肿瘤科
心血管
传染科
妇产科
神经科
儿科
呼吸
内分泌科
血液科
消化
更多科室
工具
临床工具
临床指南
医学计算与公式
ICD-10/ICD-11疾病编码
医迅达
直播
话题
公开课
精品课
科研工具
期刊数据库查询
期刊智能选择
全球基金查询
文献查询
SCI写作宝典
生物医药大词典
其他工具
下载App使用方便更快捷
Medsci 梅斯搜索
公开课
精品课
服务
科研数智化
直播,公开课与精品课
科研加速器
研究者发起的临床研究(IIS)支持
真实世界研究解决方案
药物经济学
医保准入事务
研究方案设计
数据库建立与管理
药物警戒(PV)
真实世界研究执行
数据统计分析
数字化学术传播解决方案
多渠道营销(MCM)
产品医学策略
学术传播(APO)
其它
积分商城
FAQS
#MES#
55篇内容 | 1756人围观
关注话题
话题活跃用户
#
插入话题
插入图片
评论
最新
最热
GetTopicDetailResponse(id=0c0b115e4cf, topicName=MES, introduction=MES, content=null, image=null, comments=55, allHits=1756, url=https://h5.medsci.cn/topic?id=11574, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=77620, tagList=[TagDto(tagId=77620, tagName=MES)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1590799, encodeId=431f1590e9984, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Sci Rep:给药途径对阴道生殖模型中mesoangioblasts干细胞命运的影响研究, objectType=article, longId=144559, objectId=bcaf14455944, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcaf14455944, replyNumber=0, likeNumber=73, createdTime=2018-07-18, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcaf14455944, moduleTitle=Sci Rep:给药途径对阴道生殖模型中mesoangioblasts干细胞命运的影响研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcaf14455944)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590798, encodeId=0e6c1590e986a, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Eur Heart J Qual Care Clin Outcomes:中国心梗患者仅43%认为症状与心脏有关,一半没有及时就医, objectType=article, longId=140662, objectId=df0c14066296, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df0c14066296, replyNumber=0, likeNumber=61, createdTime=2018-06-14, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df0c14066296, moduleTitle=Eur Heart J Qual Care Clin Outcomes:中国心梗患者仅43%认为症状与心脏有关,一半没有及时就医, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df0c14066296)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590797, encodeId=b8841590e974b, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=FDA向Alkermes的实验性抗抑郁药ALKS 5461发出拒绝提交函, objectType=article, longId=134233, objectId=1b76134233d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b76134233d7, replyNumber=0, likeNumber=62, createdTime=2018-04-05, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b76134233d7, moduleTitle=FDA向Alkermes的实验性抗抑郁药ALKS 5461发出拒绝提交函, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b76134233d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590796, encodeId=c9d61590e96c7, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=ACC 2018:鼓舞人心!ODYSSEY OUTCOMES研究新鲜出炉, objectType=article, longId=132086, objectId=af391320868b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af391320868b, replyNumber=0, likeNumber=71, createdTime=2018-03-12, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af391320868b, moduleTitle=ACC 2018:鼓舞人心!ODYSSEY OUTCOMES研究新鲜出炉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af391320868b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590795, encodeId=86401590e950a, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Lancet Neurol:HERMES工作组答疑:血管内血栓切除术中尽量避免采取全身麻醉, objectType=article, longId=129073, objectId=136b1290e359, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=136b1290e359, replyNumber=0, likeNumber=72, createdTime=2018-02-08, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=136b1290e359, moduleTitle=Lancet Neurol:HERMES工作组答疑:血管内血栓切除术中尽量避免采取全身麻醉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=136b1290e359)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590794, encodeId=5ba11590e9480, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Science:Mesp1基因在心脏发育中起重要作用, objectType=article, longId=128875, objectId=da491288e565, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da491288e565, replyNumber=0, likeNumber=88, createdTime=2018-02-06, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da491288e565, moduleTitle=Science:Mesp1基因在心脏发育中起重要作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da491288e565)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590793, encodeId=4b1a1590e9314, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Proteomes:尿液比较蛋白组学分析阐释了急性期反应信号和LXR/RXR激活通路在前列腺癌中下调, objectType=article, longId=126899, objectId=97a61268996f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97a61268996f, replyNumber=0, likeNumber=92, createdTime=2018-01-20, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97a61268996f, moduleTitle=Proteomes:尿液比较蛋白组学分析阐释了急性期反应信号和LXR/RXR激活通路在前列腺癌中下调, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97a61268996f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590792, encodeId=a0101590e92e3, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Kidney int:中美洲肾病(Mesoamerican nephropathy)知多少?, objectType=article, longId=123438, objectId=b41c12343813, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b41c12343813, replyNumber=0, likeNumber=63, createdTime=2017-12-16, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b41c12343813, moduleTitle=Kidney int:中美洲肾病(Mesoamerican nephropathy)知多少?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b41c12343813)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590791, encodeId=153c1590e919d, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Circ Cardiovasc Qual Outcomes:ASIAN-HF注册研究:中国仅17.9%需要植入ICD的心衰患者获得治疗, objectType=article, longId=121516, objectId=02351215168a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02351215168a, replyNumber=0, likeNumber=60, createdTime=2017-11-28, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02351215168a, moduleTitle=Circ Cardiovasc Qual Outcomes:ASIAN-HF注册研究:中国仅17.9%需要植入ICD的心衰患者获得治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02351215168a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590790, encodeId=5d021590e9055, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Circ Cardiovasc Qual Outcomes:China PEACE研究:城市医院治疗心梗患者未优于农村医院, objectType=article, longId=121514, objectId=0bc312151430, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bc312151430, replyNumber=0, likeNumber=56, createdTime=2017-11-28, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bc312151430, moduleTitle=Circ Cardiovasc Qual Outcomes:China PEACE研究:城市医院治疗心梗患者未优于农村医院, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bc312151430)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590789, encodeId=08781590e898c, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Circ Cardiovasc Qual Outcomes:中国慢病研究:大姨妈来了你不爽,不来你就危险了, objectType=article, longId=121513, objectId=a09812151352, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a09812151352, replyNumber=0, likeNumber=79, createdTime=2017-11-28, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a09812151352, moduleTitle=Circ Cardiovasc Qual Outcomes:中国慢病研究:大姨妈来了你不爽,不来你就危险了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a09812151352)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590788, encodeId=82db1590e88d5, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Circ Cardiovasc Qual Outcomes:3种非专利降压药商业化对不良事件有何影响?, objectType=article, longId=120812, objectId=463112081258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=463112081258, replyNumber=0, likeNumber=67, createdTime=2017-11-22, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=463112081258, moduleTitle=Circ Cardiovasc Qual Outcomes:3种非专利降压药商业化对不良事件有何影响?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=463112081258)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590787, encodeId=348c1590e879f, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=NPJ Biofilms Microbiomes:抗癌药变成夺命药,肠道菌群竟然还有这种“妖艳”的一面!, objectType=article, longId=118969, objectId=574411896951, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=574411896951, replyNumber=0, likeNumber=70, createdTime=2017-11-08, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=574411896951, moduleTitle=NPJ Biofilms Microbiomes:抗癌药变成夺命药,肠道菌群竟然还有这种“妖艳”的一面!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=574411896951)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590786, encodeId=19251590e86fb, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Eur Heart J - Qual Care Clin Outcomes:我国十年间冠脉搭桥手术质量进步, objectType=article, longId=117550, objectId=982911e550de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=982911e550de, replyNumber=0, likeNumber=59, createdTime=2017-10-27, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=982911e550de, moduleTitle=Eur Heart J - Qual Care Clin Outcomes:我国十年间冠脉搭桥手术质量进步, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=982911e550de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590785, encodeId=415c1590e85f7, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Health Qual Life Outcomes:屋尘螨和花粉过敏性鼻炎病人舌下免疫治疗生活品质的改善研究, objectType=article, longId=115392, objectId=ea6411539284, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea6411539284, replyNumber=0, likeNumber=68, createdTime=2017-10-09, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea6411539284, moduleTitle=Health Qual Life Outcomes:屋尘螨和花粉过敏性鼻炎病人舌下免疫治疗生活品质的改善研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea6411539284)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590784, encodeId=8fac1590e8401, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Cell:免疫疗法大牛James Allison全新:PD-1抗体与CTLA-4抗体原来如此不同, objectType=article, longId=108739, objectId=d029108e3926, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d029108e3926, replyNumber=0, likeNumber=62, createdTime=2017-08-16, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d029108e3926, moduleTitle=Cell:免疫疗法大牛James Allison全新:PD-1抗体与CTLA-4抗体原来如此不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d029108e3926)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590783, encodeId=b5f61590e8343, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Circ Cardiovasc Qual Outcomes:利伐沙班降低老年房颤患者缺血性卒中风险“男女有别”?, objectType=article, longId=104955, objectId=d89f1049559b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d89f1049559b, replyNumber=0, likeNumber=63, createdTime=2017-07-09, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d89f1049559b, moduleTitle=Circ Cardiovasc Qual Outcomes:利伐沙班降低老年房颤患者缺血性卒中风险“男女有别”?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d89f1049559b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590782, encodeId=d8af1590e821a, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Circ Cardiovasc Qual Outcomes:2型糖尿病:超过四分之三低HbA1C患者治疗强度无降低!, objectType=article, longId=104446, objectId=b657104446bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b657104446bd, replyNumber=0, likeNumber=70, createdTime=2017-07-05, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b657104446bd, moduleTitle=Circ Cardiovasc Qual Outcomes:2型糖尿病:超过四分之三低HbA1C患者治疗强度无降低!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b657104446bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590781, encodeId=46441590e81a1, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=Circ Cardiovasc Qual Outcomes:中美搭桥死亡率相似,但中国平均住院20天,美国仅7天, objectType=article, longId=102469, objectId=ac1c10246929, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac1c10246929, replyNumber=0, likeNumber=61, createdTime=2017-06-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac1c10246929, moduleTitle=Circ Cardiovasc Qual Outcomes:中美搭桥死亡率相似,但中国平均住院20天,美国仅7天, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac1c10246929)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590780, encodeId=86681590e80b1, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, objectTitle=重磅|诺贝尔奖得主“DNA之父”詹姆斯•沃森(James Watson)莅临北医纵论肿瘤治疗, objectType=article, longId=97959, objectId=ddd49e959c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddd49e959c9, replyNumber=0, likeNumber=66, createdTime=2017-05-07, rootId=0, userName=longqijun254, userId=874617863969, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddd49e959c9, moduleTitle=重磅|诺贝尔奖得主“DNA之父”詹姆斯•沃森(James Watson)莅临北医纵论肿瘤治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddd49e959c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯话题小助手
关注
已关注
MES
2020-05-29
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Sci Rep:给药途径对阴道生殖模型中mesoangioblasts干细胞命运的影响研究
73
0
2018-07-18
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Eur Heart J Qual Care Clin Outcomes:中国心梗患者仅43%认为症状与心脏有关,一半没有及时就医
61
0
2018-06-14
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
FDA向Alkermes的实验性抗抑郁药ALKS 5461发出拒绝提交函
62
0
2018-04-05
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
ACC 2018:鼓舞人心!ODYSSEY OUTCOMES研究新鲜出炉
71
0
2018-03-12
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Lancet Neurol:HERMES工作组答疑:血管内血栓切除术中尽量避免采取全身麻醉
72
0
2018-02-08
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Science:Mesp1基因在心脏发育中起重要作用
88
0
2018-02-06
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Proteomes:尿液比较蛋白组学分析阐释了急性期反应信号和LXR/RXR激活通路在前列腺癌中下调
92
0
2018-01-20
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Kidney int:中美洲肾病(Mesoamerican nephropathy)知多少?
63
0
2017-12-16
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Circ Cardiovasc Qual Outcomes:ASIAN-HF注册研究:中国仅17.9%需要植入ICD的心衰患者获得治疗
60
0
2017-11-28
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Circ Cardiovasc Qual Outcomes:China PEACE研究:城市医院治疗心梗患者未优于农村医院
56
0
2017-11-28
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Circ Cardiovasc Qual Outcomes:中国慢病研究:大姨妈来了你不爽,不来你就危险了
79
0
2017-11-28
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Circ Cardiovasc Qual Outcomes:3种非专利降压药商业化对不良事件有何影响?
67
0
2017-11-22
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
NPJ Biofilms Microbiomes:抗癌药变成夺命药,肠道菌群竟然还有这种“妖艳”的一面!
70
0
2017-11-08
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Eur Heart J - Qual Care Clin Outcomes:我国十年间冠脉搭桥手术质量进步
59
0
2017-10-27
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Health Qual Life Outcomes:屋尘螨和花粉过敏性鼻炎病人舌下免疫治疗生活品质的改善研究
68
0
2017-10-09
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Cell:免疫疗法大牛James Allison全新:PD-1抗体与CTLA-4抗体原来如此不同
62
0
2017-08-16
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Circ Cardiovasc Qual Outcomes:利伐沙班降低老年房颤患者缺血性卒中风险“男女有别”?
63
0
2017-07-09
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Circ Cardiovasc Qual Outcomes:2型糖尿病:超过四分之三低HbA1C患者治疗强度无降低!
70
0
2017-07-05
回复
仁者大医
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
Circ Cardiovasc Qual Outcomes:中美搭桥死亡率相似,但中国平均住院20天,美国仅7天
61
0
2017-06-21
回复
longqijun254
(审核中...)
关注
已关注
前往app查看评论内容
#MES#
重磅|诺贝尔奖得主“DNA之父”詹姆斯•沃森(James Watson)莅临北医纵论肿瘤治疗
66
0
2017-05-07
回复
共55条
首页
上一页
下一页
尾页
页码:
2
/3页
20条/页
扫描二维码下载梅斯医学APP
科室
订阅+
更多科室
工具
服务